YOUNGY (002192) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
12 Feb, 2026Executive summary
Revenue for H1 2025 reached ¥303.41 million, up 21.06% year-over-year, driven by a significant increase in lithium concentrate output and sales volume, despite a sharp decline in lithium salt prices and reduced lithium salt sales volume.
Net profit attributable to shareholders was ¥85.41 million, down 48.54% year-over-year, mainly due to lower lithium salt prices, reduced investment income from associates, and a decrease in government subsidies received.
Financial highlights
Operating income: ¥303.41 million, up 21.06% year-over-year.
Net profit attributable to shareholders: ¥85.41 million, down 48.54% year-over-year.
Operating cash flow: ¥179.96 million, down 35.88% year-over-year.
Basic and diluted EPS: ¥0.3289, down 48.55% year-over-year.
Gross margin for lithium concentrate: 49.58%; for lithium battery equipment: 17.00%.
Outlook and guidance
The company continues to expand lithium concentrate production capacity, with a 35,000-ton/year beneficiation project in preparation.
Lithium salt prices remain volatile; future performance will depend on market recovery and project execution.
No interim dividend, bonus shares, or capital increase from reserves planned for H1 2025.
Latest events from YOUNGY
- Lithium output doubled, driving strong profit growth and continued expansion across the value chain.002192
Q4 202524 Mar 2026 - Revenue and profit fell over 45% year-over-year amid weak lithium prices, but cash flow surged.002192
Q2 202412 Feb 2026 - Revenue and profit fell significantly amid weak lithium market conditions and investment outflows.002192
Q3 202412 Feb 2026 - Revenue and profit fell on lithium price declines, but cash flow and balance sheet remain strong.002192
Q4 202412 Feb 2026 - Revenue up 15%, but net profit and cash flow down sharply amid heavy project investment.002192
Q1 202512 Feb 2026 - Q3 revenue and profit surged on lithium sales, but year-to-date profit declined amid higher costs.002192
Q3 202512 Feb 2026